Clinical trials

  • TRASTUZUMAB DERUXTECAN for HER2-positive locally advanced or metastatic breast cancer
  • NIVOLUMAB for Head and neck squamous cell carcinoma | Head and neck cancer
  • Zoledronic acid for Hip osteoarthritis
  • NIVOLUMAB for ALK-positive anaplastic large cell lymphoma (relapsed/refractory)
  • Mifepristone for Early pregnancy loss (miscarriage)
  • DEUPSILOCIN BESILATE for Major depressive disorder
  • NIVOLUMAB for Advanced gastroesophageal carcinoma (HER2-negative, ARID1A-mutated)
  • ARFOLITIXORIN for Metastatic colorectal cancer
  • OSTEODEX for Multiple myeloma|Relapsed/refractory multiple myeloma
  • Doxorubicin hydrochloride for Node-positive breast cancer | Hormone receptor-positive HER2-negative breast cancer
  • ZIMBERELIMAB for Muscle-invasive bladder cancer
  • MERCAPTAMINE for COVID-19 (SARS-CoV-2 infection) | COVID-19 pneumonia